Understanding and treating ejaculatory dysfunction in men with diabetes mellitus.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101585129 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-2927 (Electronic) Linking ISSN: 20472919 NLM ISO Abbreviation: Andrology Subsets: MEDLINE

Original Publication: Oxford : Wiley-Blackwell, 2013-

Diabetes Mellitus*/epidemiology ; Diabetes Mellitus*/physiopathology ; Ejaculation*/physiology ; Genital Diseases, Male*/epidemiology ; Genital Diseases, Male*/etiology; Humans ; Male ; Cross-Sectional Studies ; Premature Ejaculation/epidemiology ; Premature Ejaculation/etiology ; Premature Ejaculation/physiopathology ; Retrospective Studies ; Semen

Diabetes mellitus is a rapidly rising metabolic disorder with important systemic complications. Global figures have demonstrated the prevalence of diabetes mellitus has almost quadrupled from 108 million in 1980 to 422 million in 2014, with a current prevalence of over 525 million. Of the male sexual dysfunction resulting from diabetes mellitus, significant focus is afforded to erectile dysfunction. Nevertheless, ejaculatory dysfunction constitutes important sexual sequelae in diabetic men, with up to 35%-50% of men with diabetes mellitus suffering from ejaculatory dysfunction. Despite this, aspects of its pathophysiology and treatment are less well understood than erectile dysfunction. The main disorders of ejaculation include premature ejaculation, delayed ejaculation, anejaculation and retrograde ejaculation. Although ejaculatory dysfunction in diabetes mellitus can have complex multifactorial aetiology, understanding its pathophysiological mechanisms has facilitated the development of therapies in the management of ejaculatory dysfunction. Most of our understanding of its pathophysiology is derived from diabetic animal models; however, observational studies in humans have also provided useful information in elucidating important associative factors potentially contributing to ejaculatory dysfunction in diabetic men. These have provided the potential for more tailored treatment regimens in patients depending on the ejaculatory disorder, other co-existing sequelae of diabetes mellitus, specific metabolic factors as well as the need for fertility treatment. However, evidence for treatment of ejaculatory dysfunction, especially delayed ejaculation and retrograde ejaculation, is based on low-level evidence comprising small sample-size series and retrospective or cross-sectional studies. Whilst promising findings from large randomised controlled trials have provided strong evidence for the licensed treatment of premature ejaculation, similar robust studies are needed to accurately elucidate factors predicting ejaculatory dysfunction in diabetes mellitus, as well as for the development of pharmacotherapies for delayed ejaculation and retrograde ejaculation. Similarly, more contemporary robust data are required for fertility outcomes in these patients, including methods of sperm retrieval and assisted reproductive techniques in retrograde ejaculation.
(© 2022 The Authors. Andrology published by Wiley Periodicals LLC on behalf of American Society of Andrology and European Academy of Andrology.)

Mostafa T, Abdel-Hamid IA. Ejaculatory dysfunction in men with diabetes mellitus. World J Diabetes. 2021;12(7):954-974. doi:10.4239/wjd.v12.i7.954.
WHO. Diabetes [Online]. Accessed April 14, 2022. https://www.who.int/news-room/fact-sheets/detail/diabetes.
International Diabetes Federation. The International Diabetes Federation Diabetes Atlas [Online]. 8th ed. Accessed April 14, 2022. http://www.diabetesatlas.org.
Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabetic Med. 2017;34(9):1185-1192. doi:10.1111/dme.13403.
Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2015;12(12):2291-2300. doi:10.1111/jsm.13041.
Rosen RC, Althof S. Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J Sex Med. 2008;5(6):1296-1307. doi:10.1111/j.1743-6109.2008.00825.x.
Jefferys A, Siassakos D, Wardle P. The management of retrograde ejaculation: a systematic review and update. Fertil Steril. 2012;97(2):306-312.e6. doi:10.1016/j.fertnstert.2011.11.019.
Billups KL. Erectile dysfunction as an early sign of cardiovascular disease. Int J Impot Res. 2005;17(suppl S1):S19-S24. doi:10.1038/sj.ijir.3901425.
Abdel-Hamid IA, Ali OI. Delayed ejaculation: pathophysiology, diagnosis, and treatment. World J Mens Health. 2018;36(1):22. doi:10.5534/wjmh.17051.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537-544. doi:10.1001/jama.281.6.537.
Mekonnen EG, Yeshita HY, Geremew AB. Sexual dysfunction among men with diabetes mellitus attending chronic out-patient department at the three hospitals of Northwest Amhara region, Ethiopia: prevalence and associated factors. PLoS One. 2021;16:e0256015. doi:10.1371/journal.pone.0256015.
Fedder J, Kaspersen MD, Brandslund I, Højgaard A. Retrograde ejaculation and sexual dysfunction in men with diabetes mellitus: a prospective, controlled study. Andrology. 2013;1(4):602-606. doi:10.1111/j.2047-2927.2013.00083.x.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Washington, DC: American Psychiatric Publishing; 2013:280. doi:10.1176/appi.books.9780890425596.
Rosenberg MT, Sadovsky R. Identification and diagnosis of premature ejaculation. Int J Clin Pract. 2007;61(6):903-908. doi:10.1111/j.1742-1241.2007.01337.x.
Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51(3):816-824. doi:10.1016/j.eururo.2006.07.004.
Carson C, Gunn K. Premature ejaculation: definition and prevalence. Int J Impot Res. 2006;18(suppl 1):S5-S13. doi:10.1038/sj.ijir.3901507.
Mohamed AH, Mohamud HA, Yasar A. The prevalence of premature ejaculation and its relationship with polygamous men: a cross-sectional observational study at a tertiary hospital in Somalia. BMC Urol. 2021;21(1):175. doi:10.1186/s12894-021-00942-0.
Gao J, Zhang X, Su P, et al. Prevalence and impact of premature ejaculation in outpatients complaining of ejaculating prematurely: using the instruments of intravaginal ejaculatory latency time and patient-reported outcome measures. Int J Impot Res. 2014;26(3):94-99. doi:10.1038/ijir.2013.42.
Rowland D, McMahon CG, Abdo C, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(4 pt 2):1668-1686. doi:10.1111/j.1743-6109.2010.01782.x.
Di Sante S, Mollaioli D, Gravina GL, et al. Epidemiology of delayed ejaculation. Transl Androl Urol. 2016;5(4):541-548. doi:10.21037/tau.2016.05.10.
McMahon CG. Disorders of male orgasm and ejaculation. In: Wein AJ, Kavoussi LR, Partin AW, et al., eds. Campbell-Walsh Urology. Philadelphia: Elsevier; 2016;692-708.
Parnham A, Serefoglu EC. Retrograde ejaculation, painful ejaculation and hematospermia. Transl Androl Urol. 2016;5(4):592-601. doi:10.21037/tau.2016.06.05.
Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006;24(6):645-652. doi:10.1007/S00345-006-0127-6.
Chen J. The pathophysiology of delayed ejaculation. Transl Androl Urol. 2016;5(4):549. doi:10.21037/TAU.2016.05.03.
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005;2(4):492-497. doi:10.1111/j.1743-6109.2005.00070.x.
Perelman MA. Reexamining the definitions of PE and DE. J Sex Marital Ther. 2017;43(7):633-644. doi:10.1080/0092623X.2016.1230161.
Revenig L, Leung A, Hsiao W. Ejaculatory physiology and pathophysiology: assessment and treatment in male infertility. Transl Androl Urol. 2014;3(1):41-49. doi:10.3978/J.ISSN.2223-4683.2014.02.02.
Peeters M, Giuliano F. Central neurophysiology and dopaminergic control of ejaculation. Neurosci Biobehav Rev. 2008;32(3):438-453. doi:10.1016/j.neubiorev.2007.07.013.
Alwaal A, Breyer BN, Lue TF. Normal male sexual function: emphasis on orgasm and ejaculation. Fertil Steril. 2015;104(5):1051-1060. doi:10.1016/j.fertnstert.2015.08.033.
Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science. 2002;297(5586):1566-1569. doi:10.1126/science.1073885.
Chéhensse C, Facchinetti P, Bahrami S, et al. Human spinal ejaculation generator. Ann Neurol. 2017;81(1):35-45. doi:10.1002/ana.24819.
Clement P, Giuliano F. Physiology and pharmacology of ejaculation. Basic Clin Pharmacol Toxicol. 2016;119:18-25. doi:10.1111/bcpt.12546.
Borgdorff AJ, Bernabé J, Denys P, Alexandre L, Giuliano F. Ejaculation elicited by microstimulation of lumbar spinothalamic neurons. Eur Urol. 2008;54(2):449-456. doi:10.1016/j.eururo.2008.03.043.
Baird AD, Wilson SJ, Bladin PF, Saling MM, Reutens DC. Neurological control of human sexual behaviour: insights from lesion studies. J Neurol Neurosurg Psychiatry. 2007;78(10):1042-1049. doi:10.1136/jnnp.2006.107193.
Althof SE, McMahon CG. Contemporary management of disorders of male orgasm and ejaculation. Urology. 2016;93:9-21. doi:10.1016/j.urology.2016.02.018.
Chéhensse C, Bahrami S, Denys P, Clément P, Bernabé J, Giuliano F. The spinal control of ejaculation revisited: a systematic review and meta-analysis of anejaculation in spinal cord injured patients. Hum Reprod Update. 2013;19(5):507-526. doi:10.1093/humupd/dmt029.
Koslov DS, Andersson KE. Physiological and pharmacological aspects of the vas deferens-an update. Front Pharmacol. 2013;4:101. doi:10.3389/fphar.2013.00101.
Michel MC, Vrydag W. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol. 2006;147(suppl 2):S88-S119. doi:10.1038/sj.bjp.0706619.
Giglio D, Tobin G. Muscarinic receptor subtypes in the lower urinary tract. Pharmacology. 2009;83:259-269. doi:10.1159/000209255.
Simonsen U, Comerma-Steffensen S, Andersson KE. Modulation of dopaminergic pathways to treat erectile dysfunction. Basic Clin Pharmacol Toxicol. 2016;119:63-74. doi:10.1111/bcpt.12653.
Eaton RC, Markowski VP, Lumley LA, Thompson JT, Moses J, Hull EM. D2 receptors in the paraventricular nucleus regulate genital responses and copulation in male rats. Pharmacol Biochem Behav. 1991;39(1):177-181. doi:10.1016/0091-3057(91)90418-2.
Ahlenius S, Larsson K. Effects of the dopamine D3 receptor ligand 7-OH-DPAT on male rat ejaculatory behavior. Pharmacol Biochem Behav. 1995;51(2-3):545-547. doi:10.1016/0091-3057(94)00390-5.
Ahlenius S, Larsson K, Svensson L, et al. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav. 1981;15(5):785-792. doi:10.1016/0091-3057(81)90023-X.
Oti T, Satoh K, Uta D, et al. Oxytocin influences male sexual activity via non-synaptic axonal release in the spinal cord. Curr Biol. 2021;31(1):103-114.e5. doi:10.1016/j.cub.2020.09.089.
Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400-420. doi:10.1038/s41574-021-00496-z.
Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. doi:10.1038/s41572-019-0092-1.
Tomlinson DR, Gillon KRW, Smith MG. Axonal transport of noradrenaline and noradrenergic transmission in rats with streptozotocin-induced diabetes. Diabetologia. 1982;22(3):199-204. doi:10.1007/BF00283753.
Kamata K, Kirisawa H. Changes in electrophysiological properties and noradrenaline response in vas deferens of diabetic rats. Eur J Pharmacol. 1998;350(2-3):237-241. doi:10.1016/S0014-2999(98)00271-4.
Sakai Y, Honda H. Hyperactivity of Ca channels in vasa deferentia smooth muscle of diabetic rats. Pharmacol Biochem Behav. 1987;27(2):227-229. doi:10.1016/0091-3057(87)90562-4.
Sakai Y, Aihara K, Honda H, Inazu M. Calcium mobilization and phosphatidylinositol turnover in vas deferens smooth muscle of diabetic rats. Eur J Pharmacol. 1989;162(3):475-481. doi:10.1016/0014-2999(89)90338-5.
Premkumar LS, Pabbidi RM. Diabetic peripheral neuropathy: role of reactive oxygen and nitrogen species. Cell Biochem Biophys. 2013;67(2):373-383. doi:10.1007/s12013-013-9609-5.
McVary KT, Rathnau CH, Mckenna KE. Sexual dysfunction in the diabetic BB/WOR rat: a role of central neuropathy. Am J Physiol. 1997;272(1 pt 2):R259-R267. doi:10.1152/ajpregu.1997.272.1.r259.
Yagihashi S, Sima AA. Diabetic autonomic neuropathy in the BB rat. Ultrastructural and morphometric changes in sympathetic nerves. Diabetes. 1985;34(6):558-564. doi:10.2337/diabetes.34.6.558.
Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications review-article. Cell Death Disease. 2018;9(2). doi:10.1038/s41419-017-0135-z.
Gumy LF, Bampton ETW, Tolkovsky AM. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol Cell Neurosci. 2008;37(2):298-311. doi:10.1016/j.mcn.2007.10.004.
Wang L, Chopp M, Szalad A, et al. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice. Neuroscience. 2011;193:399-410. doi:10.1016/j.neuroscience.2011.07.039.
Torimoto K, Hirao Y, Matsuyoshi H, De Groat WC, Chancellor MB, Yoshimura N. Α1-adrenergic mechanism in diabetic urethral dysfunction in rats. J Urol. 2005;173(3):1027-1032. doi:10.1097/01.ju.0000146268.45662.36.
Ibragimov A, Aliev T, Abdullaev K, Mirza-Zada V. “Sostoianie zamykatel'nogo apparata mochevogo puzyria pri retrogradnoĭ éiakuliatsii u bol'nykh sakharnym diabetom” [The function of the closure apparatus of the bladder in retrograde ejaculation in diabetics]. Urol Nefrol. 1990;3:65-68.
Ebiko M, Yonezawa A, Yoshuzumi M. Changes in ejaculatory capacity in the type I diabetic rats. Jpn J Sex Med. 2006;(21):221-232.
La Vignera S, Condorelli RA, Vicari E, et al. Seminal vesicles and diabetic neuropathy: ultrasound evaluation after prolonged treatment with a selective phosphodiesterase-5 inhibitor. Andrology. 2013;1(2):245-250. doi:10.1111/j.2047-2927.2012.00025.x.
Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes. 2001;50(8):1927-1937. doi:10.2337/diabetes.50.8.1927.
Tesfaye S, Harris N, Jakubowski JJ, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia. 1993;36(12):1266-1274. doi:10.1007/BF00400804.
Yonezawa A, Ebiko M, Yoshizumi M, et al. Effects of insulin replacement on ejaculatory dysfunction in streptozotocin-induced diabetic rats: original article: laboratory investigation. Int J Urol. 2009;16(2):208-211. doi:10.1111/j.1442-2042.2008.02214.x.
Grote CW, Groover AL, Ryals JM, Geiger PC, Feldman EL, Wright DE. Peripheral nervous system insulin resistance in ob/ob mice. Acta Neuropathol Commun. 2014;2(1):15. doi:10.1186/2051-5960-1-15.
Bivalacqua TJ, Champion HC, Usta MF, et al. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Nat Acad Sci USA. 2004;101(24):9121-9126. doi:10.1073/pnas.0400520101.
Haddad WT, Moritsugu OT, Fornazari VR, et al. Prevalence of vas deferens calcifications on abdominal CT examinations and association with systemic conditions. Am J Roentgenol. 2020;215(6):1398-1402. doi:10.2214/AJR.19.22672.
Pijl H, Meinders EA. Modulation of monoaminergic neural circuits: potential for the treatment of type 2 diabetes mellitus. Treat Endocrinol. 2002;1(2):71-78. doi:10.2165/00024677-200201020-00001.
Grunberger G. Novel therapies for the management of type 2 diabetes mellitus: Part 1. Pramlintide and bromocriptine-QR. J Diabetes. 2013;5(2):110-117. doi:10.1111/1753-0407.12034.
Pérez-Taboada I, Alberquilla S, Martín ED, et al. Diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice. Mov Disord. 2020;35(9):1636-1648. doi:10.1002/mds.28124.
Shpakov AO, Derkach KV, Berstein LM. Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Future Sci OA. 2015;1(3). doi:10.4155/fso.15.23.
Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38(8):1083-1152. doi:10.1016/S0028-3908(99)00010-6.
Majzoub A, Arafa M, Al-Said S, et al. Premature ejaculation in type II diabetes mellitus patients: association with glycemic control. Transl Androl Urol. 2016;5(2):248-254. doi:10.21037/tau.2016.03.11.
Sandrini M, Vitale G, Vergoni AV, Ottani A, Bertolini A. Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT(1A) and 5-HT2 receptors in the rat brain. Life Sci. 1997;60(16):1393-1397. doi:10.1016/S0024-3205(97)00084-2.
Nonogaki K, Strack AM, Dallman MF, Tecott LH. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT(2C) receptor gene. Nat Med. 1998;4(10):1152-1156. doi:10.1038/2647.
Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature. 1995;374(6522):542-546. doi:10.1038/374542a0.
Zhou L, Sutton GM, Rochford JJ, et al. Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 2007;6(5):398-405. doi:10.1016/j.cmet.2007.10.008.
Waldinger MD. The neurobiological approach to premature ejaculation. J Urol. 2002;168(6):2359-2367. doi:10.1016/S0022-5347(05)64146-8.
Hughes AM, Everitt BJ, Lightman SL, Todd K. Oxytocin in the central nervous system and sexual behaviour in male rats. Brain Res. 1987;414(1):133-137. doi:10.1016/0006-8993(87)91333-3.
Argiolas A, Melis MR. Central control of penile erection: role of the paraventricular nucleus of the hypothalamus. Prog Neurobiol. 2005;76(1):1-21. doi:10.1016/j.pneurobio.2005.06.002.
Sakamoto H, Matsuda KI, Zuloaga DG, et al. Sexually dimorphic gastrin releasing peptide system in the spinal cord controls male reproductive functions. Nat Neurosci. 2008;11(6):634-636. doi:10.1038/nn.2126.
Oti T, Sakamoto T, Sakamoto H. Systemic effects of oxytocin on male sexual activity via the spinal ejaculation generator in rats. Commun Integr Biol. 2021;14(1):55-60. doi:10.1080/19420889.2021.1902056.
El-Sakka AI. Premature ejaculation in non-insulin-dependent diabetic patients. Int J Androl. 2003;26(6):329-334. doi:10.1111/j.1365-2605.2003.00433.x.
Olamoyegun MA, Ayodele AO, Yemi FE, Akinyele AT. Prevalence of premature ejaculation among patients with type 2 diabetes in a tertiary health institution: a cross-sectional study. J Diabetes Mellitus. 2020;10(02):88-97. doi:10.4236/jdm.2020.102008.
Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep. 2014;14(9):1-15. doi:10.1007/s11892-014-0528-7.
Genuth S, Lipps J, Lorenzi G, et al. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287(19):2563-2569. doi:10.1001/jama.287.19.2563.
Bellastella G, Maiorino MI, Olita L, Della Volpe E, Giugliano D, Esposito K. Premature ejaculation is associated with glycemic control in type 1 diabetes. J Sex Med. 2015;12(1):93-99. doi:10.1111/jsm.12755.
Kashif S, Razdan R, Jamwal R, Goswami SK. Allantoin alleviates male sexual dysfunction in diabetic rats through augmenting the level of testosterone. J Young Pharmacists. 2018;10(1):57-61. doi:10.5530/jyp.2018.10.14.
Caruso P, Cirillo P, Carbone C, et al. Sexual dysfunctions and short-term glucose variability in young men with type 1 diabetes. Hormones. 2021;20(3):475-482. doi:10.1007/s42000-021-00295-1.
Maresch CC, Stute DC, Alves MG, Oliveira PF, de Kretser DM, Linn T. Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review. Hum Reprod Update. 2018;24(1):86-105. doi:10.1093/humupd/dmx033.
Greene LF, Kelalis PP, Weeks RE. Retrograde ejaculation of semen due to diabetic neuropathy; report of 4 cases. Fertil Steril. 1963;14:617-625. doi:10.1016/s0015-0282(16)35045-2.
Kacagan C, Nelson C, Bennett N, Mulhall J. The utility of pseudoephedrine in diabetes associated retrograde ejaculation. J Urol. 2016;195(4S):e224. doi:10.1016/j.juro.2016.02.2808.
Malavige LS, Jayaratne SD, Kathriarachchi ST, Sivayogan S, Fernando DJ, Levy JC. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. J Sex Med. 2008;5(9):2125-2134. doi:10.1111/j.1743-6109.2008.00907.x.
Malavige LS, Wijesekara P, Seneviratne Epa D, Ranasinghe P, Levy JC. Ethnic differences in sexual dysfunction among diabetic and nondiabetic males: the Oxford Sexual Dysfunction Study. J Sex Med. 2013;10(2):500-508. doi:10.1111/j.1743-6109.2012.02911.x.
Jannini EA, Lombardo F, Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl. 2005;28(2):40-45. doi:10.1111/j.1365-2605.2005.00593.x.
McMahon CG, Jannini EA, Serefoglu EC, Hellstrom WJG. The pathophysiology of acquired premature ejaculation. Transl Androl Urol. 2016;5(4):434-449. doi:10.21037/tau.2016.07.06.
Berg WT, Miner M. Hypogonadism and metabolic syndrome: review and update. Curr Opin Endocrinol Diabetes Obesity. 2020;27(6):404-410. doi:10.1097/MED.0000000000000582.
Rastrelli G, Filippi S, Sforza A, Maggi M, Corona G. Metabolic syndrome in male hypogonadism. Front Horm Res. 2018:131-155. doi:10.1159/000485999.
Seethalakshmi L, Menon M, Diamond D. The effect of streptozotocin-induced diabetes on the neuroendocrine-male reproductive tract axis of the adult rat. J Urol. 1987;138(1):190-194. doi:10.1016/S0022-5347(17)43042-4.
Neirijnck Y, Calvel P, Kilcoyne KR, et al. Insulin and IGF1 receptors are essential for the development and steroidogenic function of adult Leydig cells. FASEB J. 2018;32(6):3321-3335. doi:10.1096/fj.201700769RR.
Nutsch VL, Will RG, Tobiansky DJ, Reilly MP, Gore AC, Dominguez JM. Age-related changes in sexual function and steroid-hormone receptors in the medial preoptic area of male rats. Horm Behav. 2017;96:4-12. doi:10.1016/j.yhbeh.2017.08.008.
Williamson M, Viau V. Androgen receptor expressing neurons that project to the paraventricular nucleus of the hypothalamus in the male rat. J Comp Neurol. 2007;503(6):717-740. doi:10.1002/cne.21411.
Dabaja AA, Wosnitzer MS, Mielnik A, Bolyakov A, Schlegel PN, Paduch DA. Bulbocavernosus muscle area measurement: a novel method to assess androgenic activity. Asian J Androl. 2014;16(4):618-622. doi:10.4103/1008-682X.123681.
Murashima A, Kishigami S, Thomson A, Yamada G. Androgens and mammalian male reproductive tract development. Biochim Biophys Acta. 2015;1849(2):163-170. doi:10.1016/j.bbagrm.2014.05.020.
Corona G, Jannini EA, Mannucci E, et al. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med. 2008;5(8):1991-1998. doi:10.1111/j.1743-6109.2008.00803.x.
Coskuner ER, Ozkan B. Premature ejaculation and endocrine disorders: a literature review. World J Mens Health. 2021;39(1):38. doi:10.5534/WJMH.200184.
Cohen PG. The association of premature ejaculation and hypogonadotropic hypogonadism. J Sex Marital Ther. 1997;23(3):208-211. doi:10.1080/00926239708403925.
Tahtali İN. Is testosterone replacement an effective treatment of secondary premature ejaculation? Andrologia. 2020;52(1). doi:10.1111/and.13452.
Zhao J, Ma Y, Zhai X, Li H, Wang Z, Chong T. Elevated free testosterone levels and reduced very low-density lipoprotein levels in men with lifelong premature ejaculation: a preliminary study. J Int Med Res. 2021;49(4):030006052110026. doi:10.1177/03000605211002681.
Owiredu WKBA, Amidu N, Alidu H, Sarpong C, Gyasi-Sarpong CK. Determinants of sexual dysfunction among clinically diagnosed diabetic patients. Reprod Biol Endocrinol. 2011;9(1). doi:10.1186/1477-7827-9-70.
Corona G, Jannini EA, Lotti F, et al. Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu. Int J Androl. 2011;34(1):41-48. doi:10.1111/j.1365-2605.2010.01059.x.
Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat Rev Urol. 2012;9(9):508-519. doi:10.1038/nrurol.2012.147.
Wu F, Chen T, Mao S, Jiang H, Ding Q, Xu G. Levels of estradiol and testosterone are altered in Chinese men with sexual dysfunction. Andrology. 2016;4(5):932-938. doi:10.1111/andr.12195.
Paduch DA, Polzer PK, Ni X, Basaria S. Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial. J Clin Endocrinol Metab. 2015;100(8):2956-2962. doi:10.1210/jc.2014-4434.
Morgentaler A, Polzer P, Althof S, et al. Delayed ejaculation and associated complaints: relationship to ejaculation times and serum testosterone levels. J Sex Med. 2017;14(9):1116-1124. doi:10.1016/j.jsxm.2017.06.013.
Pontes DA, Fernandes GSA, Piffer RC, Gerardin DCC, Pereira OCM, Kempinas WG. Ejaculatory dysfunction in streptozotocin-induced diabetic rats: the role of testosterone. Pharmacol Rep. 2011;63(1):130-138. doi:10.1016/S1734-1140(11)70407-8.
Burke JP, Jacobson DJ, McGree ME, et al. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J Urol. 2007;177(4):1438-1442. doi:10.1016/j.juro.2006.11.059.
Corona G, Mannucci E, Petrone L, et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006;18(2):190-197. doi:10.1038/sj.ijir.3901391.
Khan HL, Bhatti S, Abbas S, et al. Longer trinucleotide repeats of androgen receptor are associated with higher testosterone and low oxytocin levels in diabetic premature ejaculatory dysfunction patients. Basic Clin Androl. 2018;28(1). doi:10.1186/s12610-018-0068-0.
Irfan M, Hussain NHN, Noor NM, Mohamed M, Sidi H, Ismail SB. Epidemiology of male sexual dysfunction in Asian and European regions: a systematic review. Am J Mens Health. 2020;14(4):155798832093720. doi:10.1177/1557988320937200.
Mostafa T, Abdel-Hamid IA, Taymour M, Ali OI. Gene variants in premature ejaculation: systematic review and future directions. Sex Med Rev. 2020;8(4):586-602. doi:10.1016/j.sxmr.2020.07.002.
Wang F, Luo D, Chen J, et al. Genome-wide association analysis to search for new loci associated with lifelong premature ejaculation risk in Chinese male Han population. World J Mens Health. 2022;40(2):330-339. doi:10.5534/wjmh.210084.
Bąk E, Marcisz C, Krzemińska S, Dobrzyn-Matusiak D, Foltyn A, Drosdzol-Cop A. Relationships of sexual dysfunction with depression and acceptance of illness in women and men with type 2 diabetes mellitus. Int J Environ Res Public Health. 2017;14(9):1073. doi:10.3390/ijerph14091073.
Asefa A, Nigussie T, Henok A, Mamo Y. Prevalence of sexual dysfunction and related factors among diabetes mellitus patients in Southwest Ethiopia. BMC Endocrine Disorders. 2019;19(1):141. doi:10.1186/s12902-019-0473-1.
Corona G, Giorda CB, Cucinotta D, Guida P, Nada E, Aglialoro A, et al. Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors. J Sex Med. 2014;11(8):2065-2073. doi:10.1111/jsm.12601.
Culha MG, Tuken M, Gonultas S, Cakir OO, Serefoglu EC. Frequency of etiological factors among patients with acquired premature ejaculation: prospective, observational, single-center study. Int J Impot Res. 2020;32(3):352-357. doi:10.1038/s41443-019-0188-x.
Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med. 2012;9(6):1497-1507. doi:10.1111/j.1743-6109.2012.02709.x.
Maalmi H, Herder C, Bönhof GJ, et al. Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes. Diabetologia. 2022;65:552-562. doi:10.1007/s00125-021-05607-z.
Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology Guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol. 2021;80(3):333-357. doi:10.1016/J.EURURO.2021.06.007.
Melnik T, Althof S, Atallah ÁN, Dos Santos Puga ME, Glina S, Riera R. Psychosocial interventions for premature ejaculation. Cochrane Database System Rev. 2011;8:CD00895. doi:10.1002/14651858.cd008195.pub2.
McMahon CG, Stuckey BGA, Andersen M, et al. Efficacy of sildenafil citrate (viagra) in men with premature ejaculation. J Sex Med. 2005;2(3):368-375. doi:10.1111/j.1743-6109.2005.20351.x.
Aversa A, Pili M, Francomano D, et al. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res. 2009;21(4):221-227. doi:10.1038/ijir.2009.21.
McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed. J Urol. 1999:1826-1830. doi:10.1097/00005392-199906000-00026.
Atmaca M, Kuloglu M, Tezcan E, Semercioz A. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res. 2002;14(6):502-505. doi:10.1038/sj.ijir.3900918.
Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368(9539):929-937. doi:10.1016/S0140-6736(06)69373-2.
Porst H, McMahon CG, Althof SE, et al. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: Integrated analyses of two phase 3 dapoxetine trials. J Sex Med. 2010;7(6):2231-2242. doi:10.1111/j.1743-6109.2010.01820.x.
Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004;16(4):369-381. doi:10.1038/sj.ijir.390117.
Tuken M, Culha MG, Serefoglu EC. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED study. Int J Impot Res. 2019;31(2):92-96. doi:10.1038/s41443-019-0122-2.
Sun Y, Luo D, Yang L, et al. Efficacy of phosphodiesterase-5 inhibitor in men with premature ejaculation: a new systematic review and meta-analysis. Urology. 2015;86(5):947-955. doi:10.1016/j.urology.2015.06.051.
Hisasue SI. The drug treatment of premature ejaculation. Transl Androl Urol. 2016;5(4):482-486. doi:10.21037/tau.2016.06.10.
Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339(7718):431-434. doi:10.1136/bmj.b2880.
Dinsmore WW, Wyllie MG. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int. 2009;103(7):940-949. doi:10.1111/j.1464-410X.2009.08456.x.
Porst H, Burri A. FortacinTM spray for the treatment of premature ejaculation. Urologia. 2017;84(2):1-10. doi:10.5301/uj.5000275.
Pu C, Yang L, Liu L, Yuan H, Wei Q, Han P. Topical anesthetic agents for premature ejaculation: a systematic review and meta-analysis. Urology. 2013;81(4):799-804. doi:10.1016/j.urology.2012.12.028.
Sutton M, Hunn C, Summers-Colquitt RB, et al. Promescent has a cytotoxic impact on fresh human sperm in vitro. Urology. 2018;114:95-98. doi:10.1016/j.urology.2017.12.027.
Park YW, Kim Y, Lee JH. Antipsychotic-induced sexual dysfunction and its management. World J Mens Health. 2012;30(3):153. doi:10.5534/wjmh.2012.30.3.153.
Abdel-Hamid IA, Elsaied MA, Mostafa T. The drug treatment of delayed ejaculation. Transl Androl Urol. 2016;5(4):576-591. doi:10.21037/tau.2016.05.05.
Butcher MJ, Welliver RC, Sadowski D, Botchway A, Köhler TS. How is delayed ejaculation defined and treated in North America? Andrology. 2015;3(3):626-631. doi:10.1111/andr.12041.
Krüger THC, Haake P, Haverkamp J, et al. Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol. 2003;179(3):357-365. doi:10.1677/joe.0.1790357.
Modell JG, May RS, Katholi CR. Effect of bupropion-sr on orgasmic dysfunction in nondepressed subjects: a pilot study. J Sex Marital Ther. 2000;26(3):231-240. doi:10.1080/00926230050084623.
Killian LM, Docherty JR. Cardiovascular stimulant actions of bupropion in comparison to cocaine in the rat. Eur J Pharmacol. 2014;735(1):32-37. doi:10.1016/j.ejphar.2014.03.059.
Cavariani MM, de Almeida Kiguti LR, de Lima Rosa J, et al. Bupropion treatment increases epididymal contractility and impairs sperm quality with no effects on the epididymal sperm transit time of male rats. J Appl Toxicol. 2015;35(9):1007-1016. doi:10.1002/jat.3089.
Nelson CJ, Ahmed A, Valenzuela R, Parker M, Mulhall JP. Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm. Urology. 2007;69(3):552-555. doi:10.1016/j.urology.2006.02.048.
Soler JM, Previnaire JG, Plante P, Denys P, Chartier-Kastler E. Midodrine improves orgasm in spinal cord-injured men: the effects of autonomic stimulation. J Sex Med. 2008;5(12):2935-2941. doi:10.1111/j.1743-6109.2008.00844.x.
Lu S, Cui Y, Li X, et al. Sperm retrieval in anejaculatory diabetic men who failed in drug treatment and penile vibratory stimulation during blood sugar under control. Andrologia. 2014;46(4):370-373. doi:10.1111/and.12087.
Głowacka K, Wiela-Hojeńska A. Pseudoephedrine-benefits and risks. Int J Mol Sci. 2021;22(10):5146. doi:10.3390/ijms22105146.
Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med. 2008;5(1):194-198. doi:10.1111/j.1743-6109.2007.00456.x.
Shoshany O, Abhyankar N, Elyaguov J, Niederberger C. Efficacy of treatment with pseudoephedrine in men with retrograde ejaculation. Andrology. 2017;5(4):744-748. doi:10.1111/andr.12361.
Safarinejad MR. Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study. Int J Impot Res. 2009;21(4):213-220. doi:10.1038/ijir.2009.19.
Gilja I, Parazajder J, Radej M, Cvitkovic P, Kovacic M. Retrograde ejaculation and loss of emission: possibilities of conservative treatment. Eur Urol. 1994;25(3):226-228. doi:10.1159/000475288.
Burcelin R, Thorens B, Glauser M, Gaillard RC, Pralong FP. Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin. Endocrinology. 2003;144(10):4484-4491. doi:10.1210/en.2003-0457.
Schoeller EL, Albanna G, Frolova AI, Moley KH. Insulin rescues impaired spermatogenesis via the hypothalamic-pituitary-gonadal axis in Akita diabetic mice and restores male fertility. Diabetes. 2012;61(7):1869-1878. doi:10.2337/db11-1527.
Bucholtz DC, Chiesa A, Pappano WN, et al. Regulation of pulsatile luteinizing hormone secretion by insulin in the diabetic male lamb. Biol Reprod. 2000;62(5):1248-1255. doi:10.1095/biolreprod62.5.1248.
Lampiao F, du Plessis SS. Insulin and leptin enhance human sperm motility, acrosome reaction and nitric oxide production. Asian J Androl. 2008;10(5):799-807. doi:10.1111/j.1745-7262.2008.00421.x.
Hicks JJ, Rojas L, Rosado A. Insulin regulation of spermatozoa metabolism. Endocrinology 1973;92(3):833-839.
Bertoldo MJ, Guibert E, Tartarin P, Guillory V, Froment P. Effect of metformin on the fertilizing ability of mouse spermatozoa. Cryobiology. 2014;68(2):262-268. doi:10.1016/j.cryobiol.2014.02.006.
Attia SM, Helal GK, Alhaider AA. Assessment of genomic instability in normal and diabetic rats treated with metformin. Chem Biol Interact. 2009;180(2):296-304. doi:10.1016/j.cbi.2009.03.001.
Banihani SA. Effect of metformin on semen quality. Braz J Pharma Sci. 2016;52:591-594. doi:10.1590/S1984-82502016000400002.
Reynolds JC, Mccall A, Kim ED, Lipshultz LI. Bladder neck collagen injection restores antegrade ejaculation after bladder neck surgery. J Urol. 1998;1303. doi:10.1097/00005392-199804000-00065.
Kurbatov D, Russo GI, Galstyan GR, et al. Correction of retrograde ejaculation in patients with diabetes mellitus using endourethral collagen injection: preliminary results. J Sex Med. 2015;12(11):2126-2129. doi:10.1111/jsm.13024.
Yavetz H, Yogev L, Hauser R, Lessing JB, Paz G, Homonnai ZT. Retrograde ejaculation. Hum Reprod. 1994;9(3):381-386. doi:10.1093/oxfordjournals.humrep.a138513.
Crich JP, Jequier AM. Infertility in men with retrograde ejaculation: the action of urine on sperm motility, and a simple method for achieving antegrade ejaculation. Fertil Steril. 1978;30(5):572-576. doi:10.1016/S0015-0282(16)43640-X.
Hotchkiss RS, Pinto AB, Kleegman S. Artificial insemination with semen recovered from the bladder. Fertil Steril. 1955;6(1):37-42. doi:10.1016/s0015-0282(16)31863-5.
Philippon M, Karsenty G, Bernuz B, et al. Successful pregnancies and healthy live births using frozen-thawed sperm retrieved by a new modified Hotchkiss procedure in males with retrograde ejaculation: first case series. Basic Clin Androl. 2015;25(1):5. doi:10.1186/s12610-015-0021-4.
Liu X, Gao M, Sun J, et al. Effects of testicular sperm aspiration upon first cycle ICSI-ET for type 2 diabetic male patients. Syst Biol Reprod Med. 2020;66(6):355-363. doi:10.1080/19396368.2020.1785042.

Keywords: anejaculation; autonomic neuropathy; delayed ejaculation; diabetes mellitus; ejaculatory dysfunction; pathophysiology; premature ejaculation; retrograde ejaculation; sexual dysfunction

Date Created: 20220807 Date Completed: 20230122 Latest Revision: 20230217

20231215

10.1111/andr.13262

35933708